CRWV Vs. QQQ: Buy CoreWeave for Explosive AI Alpha or Hold QQQ for Insulated Macro Safety?

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • CoreWeave (CRWV) grew revenue 112% and posted its strongest bookings quarter ever, yet shares cratered 31% while QQQ lost just 5%.

  • Jane Street's plan to self-build a 200 MW data center despite a $6B CoreWeave commitment fuels fears hyperscalers may eventually bypass GPU cloud providers.

  • At $82 with a $143 analyst target, CoreWeave looks undervalued, but $50B in liabilities and negative free cash flow favor QQQ for most investors.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and CoreWeave, Inc. Class A Common Stock didn't make the cut. Grab the names FREE today.

CRWV Vs. QQQ: Buy CoreWeave for Explosive AI Alpha or Hold QQQ for Insulated Macro Safety?

© Jupiterimages / Getty Images

CoreWeave (NASDAQ:CRWV) and Invesco QQQ Trust (NASDAQ:QQQ) just gave investors two very different reads on the AI trade. CoreWeave posted its strongest bookings quarter ever, then watched shares slide on customer concentration fears. QQQ, the Nasdaq-100 basket, absorbed the same tech turbulence with barely a scratch. One is a levered GPU cloud pure-play. The other spreads that bet across a hundred names.

Bookings Explode. The Stock Cracks Anyway.

CoreWeave’s May 7, 2026 report delivered revenue of $2.08 billion, up 111.7% year over year and beating consensus by 5.80%. Under the hood, the picture got heavier. EPS printed -$1.40, missing expectations, and net loss widened to $740 million from $315 million a year earlier. Capex hit $7.70 billion in a single quarter.

CEO Michael Intrator framed the setup around scale, not profits. “This was the strongest bookings quarter in CoreWeave’s history, with revenue backlog reaching nearly $100 billion,” he said, adding that active power surpassed 1 GW on the way to 8 GW by 2030. A $21 billion Meta commitment anchored the quarter.

QQQ has no earnings report, but its constituents (Apple, Microsoft, NVIDIA, Amazon, Alphabet, Meta) delivered the collective results that kept the basket steady. Over the last month, QQQ slipped 4.5%. CoreWeave lost 31.46%. That performance gap captures the trade-off between concentrated GPU exposure and diversified mega-cap tech.

Concentrated GPU Bet vs. Hundred-Name Cushion

Lens CoreWeave QQQ
Core exposure AI GPU cloud, single customer set 100 Nasdaq large caps, diversified
Revenue backlog $99.4 billion N/A (index fund)
1-year return -46.14% +29.38%
Key vulnerability Debt load, customer concentration Mega-cap tech drawdowns

CoreWeave carries $50.81 billion in total liabilities and interest expense of $536 million that doubled year over year. The recent slide followed Jane Street’s June 6 disclosure that it plans to build its own 100 to 200 MW data center despite a $6 billion CoreWeave commitment, feeding fears that hyperscaler customers may self-build. A securities lawsuit notice filed June 29 added to the pressure.

What Decides the Next Six Months

I will be watching whether CoreWeave’s inference-focused pivot, including Dedicated Inference and CoreWeave ARENA, converts backlog into cash before interest expense compounds further. Free cash flow ran -$4.71 billion last quarter. For QQQ, the tell is whether mega-cap AI spenders keep guiding capex higher. If they blink, the basket does too, just less violently.

Why I Lean QQQ Unless You Have Iron Nerves

Personally, at $81.75, CoreWeave looks tempting against the $143.41 analyst target. Reddit sentiment stayed bullish in the 65 to 72 range through the pullback, so retail conviction is intact. But the take-or-pay backlog only matters if the balance sheet holds. For risk-averse allocations, QQQ offers the same AI exposure through a diversified basket, while CoreWeave carries single-name concentration and balance-sheet risk. A normalization in input costs and insider selling would strengthen the CoreWeave setup. Until then, the diversified basket is the calmer way to own the same AI story.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

AKAM Vol: 7,019,527
ANET Vol: 11,854,822
SMCI Vol: 36,638,527
VLO Vol: 3,866,753
BKR Vol: 16,350,325

Top Losing Stocks

SYF Vol: 9,338,709
CTRA Vol: 73,319,495
MRNA Vol: 6,534,442
AXON Vol: 1,153,193
RMD Vol: 1,733,114